This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Irisys, Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Gerald Yakatan: Innovator in Liposomal Anticancer Compositions
Introduction
Gerald Yakatan is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative work on liposomal anticancer compositions. His research focuses on enhancing the efficacy of chemotherapeutic agents, which is crucial in the fight against cancer.
Latest Patents
Gerald Yakatan holds a patent for liposomal anticancer compositions. This patent includes methods and compositions for the treatment of cancer, specifically involving liposome encapsulated chemotherapeutic agents. The invention encompasses a weakly basic anticancer compound and an acid or salt thereof, wherein the acid is either oxalic acid or tartaric acid. The methods for preparing and utilizing these compositions are also described in the patent.
Career Highlights
Gerald Yakatan has dedicated his career to advancing cancer treatment methodologies. His work at Irisys, Inc. has positioned him as a key player in the development of innovative therapeutic solutions. His patent reflects his commitment to improving patient outcomes through scientific research and innovation.
Collaborations
Gerald has collaborated with notable professionals in his field, including Robert Giannini and Igor Nikoulin. These collaborations have likely contributed to the depth and breadth of his research, enhancing the impact of his work in cancer treatment.
Conclusion
Gerald Yakatan's contributions to the field of cancer treatment through his patent on liposomal anticancer compositions highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire advancements in cancer therapies.